Cargando…
CB(1) Ligand AM251 Induces Weight Loss and Fat Reduction in Addition to Increased Systemic Inflammation in Diet-Induced Obesity
Diet-induced obesity (DIO) reduces fatty acid oxidation in skeletal muscle and decreases circulating levels of adiponectin. Endocannabinoid signaling is overactive in obesity, with some effects abated by antagonism of cannabinoid receptor 1 (CB(1)). This research aimed to determine if treatment with...
Autores principales: | O’Keefe, Lannie, Vu, Teresa, Simcocks, Anna C., Jenkin, Kayte A., Mathai, Michael L., Hryciw, Deanne H., Hutchinson, Dana S., McAinch, Andrew J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9569643/ https://www.ncbi.nlm.nih.gov/pubmed/36232744 http://dx.doi.org/10.3390/ijms231911447 |
Ejemplares similares
-
Treatment of Diet-Induced Obese Rats with CB(2) Agonist AM1241 or CB(2) Antagonist AM630 Reduces Leptin and Alters Thermogenic mRNA in Adipose Tissue
por: O’Keefe, Lannie, et al.
Publicado: (2023) -
Atypical cannabinoid ligands O-1602 and O-1918 administered chronically in diet-induced obesity
por: Simcocks, Anna C, et al.
Publicado: (2019) -
The Role of Atypical Cannabinoid Ligands O-1602 and O-1918 on Skeletal Muscle Homeostasis with a Focus on Obesity
por: Simcocks, Anna C., et al.
Publicado: (2020) -
Fatty Acid Modulation of the Endocannabinoid System and the Effect on Food Intake and Metabolism
por: Naughton, Shaan S., et al.
Publicado: (2013) -
Anti-Obesity Effect of the CB2 Receptor Agonist JWH-015 in Diet-Induced Obese Mice
por: Verty, A. N. A., et al.
Publicado: (2015)